Table 3.
Unadjusted population average (GEE) models1 of HPV Vaccination Outcomes (Initiation, Series Completion, Hesitancy) and geographic-based socioeconomic factors by male and female child (n = 909)
| Geographic-based socioeconomic factors | Initiation | Series Completion | Hesitancy | |||
|---|---|---|---|---|---|---|
| Males (n = 471) |
Females (n = 438) |
Males (n = 471) |
Females (n = 438) |
Males (n = 471) |
Females (n = 438) |
|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| Medically Underserved Area (MUA) vs. Non-MUA | 0.98 (0.78–1.24) | 0.99 (0.67–1.47) | 1.02 (0.75–1.39) | 1.05 (0.76–1.45) | 1.19 (0.78–1.80) | 1.20 (0.68–2.10) |
| Healthcare Provider Shortage Area (HPSA) vs. non-HPSA | 1.14 (0.67–1.94) | 0.82 (0.47–1.42) | 1.48 (0.89–2.46) | 0.61 (0.52–0.71)* | 0.80 (0.45–1.41) | 1.13 (0.63–2.04) |
| Persistent poverty vs. none | 2.00 (0.73–5.48) | 1.31 (0.52–3.26) | 1.92 (0.59–6.19) | 1.04 (0.35–3.10) | 0.46 (0.26–0.84)* | 1.07 (0.54–2.11) |
| Persistent child poverty vs. none | 0.95 (0.42–2.13) | 0.58 (0.35–0.95)* | 1.42 (0.60–3.34) | 0.63 (0.34–1.17) | 0.83 (0.62–1.11) | 1.10 (0.67–1.79) |
| High social2 vulnerability vs. low3 | 0.89 (0.55–1.45) | 0.95 (0.62–1.48) | 1.32 (0.64–2.71) | 1.01 (0.58–1.75) | 0.45 (0.43–0.47)* | 1.23 (0.97–1.56) |
OR = odds ratio; 95% CI = 95% confidence interval
* statistically significant at alpha level of < 0.05
1 Population average model/GEE– clustered on state
2 High vulnerability measured as Social Vulnerability Index ≥ 0.7
3 Low vulnerability measured as Social Vulnerability Index < 0.7